LATEST ON VANTAGE ASIA
If a Chinese medical research institute applies for the patent of a US brand-name drug that might cure COVID-19, as a ‘secondary use’ invention does it constitute squatting?
MOST READ ON VANTAGE ASIA
Intellectual property protection faces new challenges as the world readjusts to a post-pandemic reality and its associated trade tensions
ere we glean the opinions of three elite GCs from different industries, who share their observations and strategies on team management and communication
How will the courts respond to an anticipated deluge of disputes relating to frustration of contracts in a post-COVID-19 world?
With COVID-19 forcing companies to implement work-from-home policies, Jim Fitzsimmons helps us understand the cybersecurity risks posed by a remote workforce
Asia Business Law Journal reveals the top 100 lawyers practising in Indonesia